By performing a large-scale biobank-based genome-wide association study, we identified a strong link between the underlying risk of cardiometabolic disease and patterns of lifelong medication use in hyperlipidemia, hypertension and type 2 diabetes. We discover hundreds of genetic predictors of medication use behavior and show medication-use-enhanced applications for polygenic prediction in cardiometabolic diseases.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
James, S. L. et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392, 1789–1858 (2018). A review article that presents global burden of 354 disease including cardiovascular diseases.
Marenberg, M. E., Risch, N., Berkman, L. F., Floderus, B. & de Faire, U. Genetic susceptibility to death from coronary heart disease in a study of twins. New Engl. J. Med. 330, 1041–1046 (1994). This paper reports heritability estimates for coronary heart disease.
SEARCH Collaborative Group. SLCO1B1 variants and statin-induced myopathy—a genomewide study. New Engl. J. Med. 359, 789–799 (2008). A review article that presents evidence for adverse reactions to statin use for individuals carrying risk variants in the SLCO1B1 gene.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This is a summary of: Kiiskinen, T. et al. Genetic predictors of lifelong medication use patterns in cardiometabolic diseases. Nat. Med. https://doi.org/10.1038/s41591-022-02122-5 (2023).
Rights and permissions
About this article
Cite this article
Genetic prediction of medication use patterns in cardiometabolic disease. Nat Med 29, 43–44 (2023). https://doi.org/10.1038/s41591-022-02124-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-022-02124-3
